Byrnihat battles respiratory issues, skin rashes
1
2
Byrnihat: Two-year-old Sumaiya Ansari, a resident of Byrnihat town, which is ranked as the world's most polluted metropolitan area by Swiss Group IQAir, was battling breathing problems for several days before she was hospitalised in March and given oxygen support.
She is among many residents of the industrial town on the border of Assam and Meghalaya — otherwise known for their lush, natural beauty — inflicted by illnesses that doctors say are likely linked to high exposure to pollution.
Byrnihat's annual average PM2.5 concentration in 2024 was 128.2 micrograms per cubic meter, according to IQAir, over 25 times the level recommended by WHO.
PM2.5 refers to particulate matter measuring 2.5 microns or less in diameter that can be carried into the lungs, causing deadly diseases and cardiac problems.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Trade Bitcoin & Ethereum – No Wallet Needed!
IC Markets
Start Now
Undo
"It was very scary, she was breathing like a fish," said Abdul Halim, Ansari's father, who brought her home from hospital after two days.
According to govt data, the number of respiratory infection cases in the region rose to 3,681 in 2024 from 2,082 in 2022.
"Ninety percent of the patients we see daily come either with a cough or other respiratory issues," said Dr J Marak of Byrnihat Primary Healthcare Centre.
Residents say the toxic air also causes skin rashes, eye irritation and other health problems, damages crops, and restricts routine tasks like drying laundry outdoors. "Everything is covered with dust or soot," said farmer Dildar Hussain.
Unlike other parts of India that face pollution every winter, Byrnihat's air quality remains poor through the year, govt data indicates.
Home to about 80 industries - many of them highly polluting - experts say the problem is exacerbated in the town by other factors like emissions from heavy vehicles, and its 'bowl-shaped topography'.
"Sandwiched between the hilly terrain of Meghalaya and the plains of Assam, there is no room for pollutants to disperse," said Arup Kumar Misra, chairman of Assam's pollution control board.
The town's location has also made a solution tougher, with the states shifting blame to each other, said a Meghalaya government official who did not want to be named.
Since the release of IQAir's report in March, however, Assam and Meghalaya have agreed to form a joint committee and work together to combat Byrnihat's pollution. Reuters
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Measles cases surging globally. Should children be vaccinated earlier?
Sydney: Measles has been rising globally in recent years. There were an estimated 10.3 million cases worldwide in 2023, a 20 per cent increase from 2022. Outbreaks are being reported all over the world including in the United States, Europe and the Western Pacific region (which includes Australia ). For example, Vietnam has reportedly seen thousands of cases in 2024 and 2025. In Australia, 77 cases of measles have been recorded in the first five months of 2025, compared with 57 cases in all of 2024. Measles cases in Australia are almost all related to international travel. They occur in travellers returning from overseas, or are contracted locally after mixing with an infected traveller or their contacts. Measles most commonly affects children and is preventable with vaccination, given in Australia in two doses at 12 and 18 months old. But in light of current outbreaks globally, is there a case for reviewing the timing of measles vaccinations? Some measles basics Measles is caused by a virus belonging to the genus Morbillivirus. Symptoms include a fever, cough, runny nose and a rash. While it presents as a mild illness in most cases, measles can lead to severe disease requiring hospitalisation, and even death. Large outbreaks can overwhelm health systems. Measles can have serious health consequences, such as in the brain and the immune system, years after the infection. Measles spreads from person to person via small respiratory droplets that can remain suspended in the air for two hours. It's highly contagious - one person with measles can spread the infection to 12-18 people who aren't immune. Because measles is so infectious, the World Health Organization (WHO) recommends two-dose vaccination coverage above 95 per cent to stop the spread and achieve "herd immunity". Low and declining vaccine coverage, especially since the COVID pandemic, is driving global outbreaks. When are children vaccinated against measles? Newborn babies are generally protected against measles thanks to maternal antibodies. Maternal antibodies get passed from the mother to the baby via the placenta and in breast milk, and provide protection against infections including measles. The WHO advises everyone should receive two doses of measles vaccination. In places where there's a lot of measles circulating, children are generally recommended to have the first dose at around nine months old. This is because it's expected maternal antibodies would have declined significantly in most infants by that age, leaving them vulnerable to infection. If maternal measles antibodies are still present, the vaccine is less likely to produce an immune response. Research has also shown a measles vaccine given at less than 8.5 months of age can result in an antibody response which declines more quickly. This might be due to interference with maternal antibodies, but researchers are still trying to understand the reasons for this. A second dose of the vaccine is usually given 6-9 months later. A second dose is important because about 10-15 per cent of children don't develop antibodies after the first vaccine. In settings where measles transmission is under better control, a first dose is recommended at 12 months of age. Vaccination at 12 months compared with nine months is considered to generate a stronger, longer-lasting immune response. In Australia, children are routinely given the measles-mumps- rubella ( MMR ) vaccine at 12 months and the measles-mumps-rubella-varicella (MMRV, with "varicella" being chickenpox) vaccine at 18 months. Babies at higher risk of catching the disease can also be given an additional early dose. In Australia, this is recommended for infants as young as six months when there's an outbreak or if they're travelling overseas to a high-risk setting. A new study looking at measles antibodies in babies A recent review looked at measles antibody data from babies under nine months old living in low- and middle-income countries. The review combined the results from 20 studies, including more than 8,000 babies. The researchers found that while 81 per cent of newborns had maternal antibodies to measles, only 30 per cent of babies aged four months had maternal antibodies. This study suggests maternal antibodies to measles decline much earlier than previously thought. It raises the question of whether the first dose of measles vaccine is given too late to maximise infants' protection, especially when there's a lot of measles around. Should we bring the measles vaccine forward in Australia? All of the data in this study comes from low- and middle-income countries, and might not reflect the situation in Australia where we have much higher vaccine coverage for measles, and very few cases. Australia's coverage for two doses of the MMR vaccine at age two is above 92 per cent. Although this is lower than the optimal 95 per cent, the overall risk of measles surging in Australia is relatively low. Nonetheless, there may be a case for broadening the age at which an early extra dose of the measles vaccine can be given to children at higher risk. In New Zealand, infants as young as four months can receive a measles vaccine before travelling to an endemic country. But the current routine immunisation schedule in Australia is unlikely to change. Adding an extra dose to the schedule would be costly and logistically difficult. Lowering the age for the first dose may have some advantages in certain settings, and doesn't pose any safety concerns, but further evidence would be required to support this change. In particular, research is needed to ensure it wouldn't negatively affect the longer-term protection that vaccination offers from measles. Making sure you're protected In the meantime, ensuring high levels of measles vaccine coverage with two doses is a global priority. People born after 1966 are recommended to have two doses of measles vaccine. This is because those born before the mid-1960s likely caught measles as children (when the vaccine was not yet available) and would therefore have natural immunity. If you're unsure about your vaccination status, you can check this through the Australian Immunisation Register . If you don't have a documented record, ask your doctor for advice. Catch-up vaccination is available under the National Immunisation Programme . (The Conversation) PY PY
Time of India
2 hours ago
- Time of India
The healing power of Acupuncture: How wellness centres are reviving an ancient science
In a world dominated by modern medicine, where pills and surgeries often come with side effects and uncertainties, there is a powerful revival of traditional healing methods. And one such therapy is Acupuncture, which is slowly becoming a part and parcel of holistic health. What is Acupuncture? Acupuncture is a form of therapy in which very fine needles are inserted into specific points on the body, known as acupoints or marma points. It is believed that these tiny needles do not just physically stimulate, but also regulate the energy when they hit the marma points. Acupuncture works by correcting the imbalances in the marma points and the 'QI' of the body. And surprisingly, very few people know that there are more than 360 acupoints across the body, each linked to specific organs and functions, and stimulating these points helps in opening up blocked energy pathways, balancing body systems, and restoring harmony. Acupuncture offerings by Patanjali Patanjali Wellness, under the guidance of Acharya Balkrishna and Swami Ramdev, has integrated acupuncture into its wide range of natural healing therapies. Patanjali's acupuncture therapy is offered as part of its larger wellness ecosystem that includes Ayurveda , Panchakarma, naturopathy, yoga, and physiotherapy. And at Patanjali, there are 5 major types of Acupuncture techniques in play - Cupping method that uses suction cups to draw out toxins and stimulate circulation, Ear Acupuncture, which focuses on the ear as a micro-system of the whole body, Electro-Acupuncture, which is a mix of traditional needling with mild electrical currents, Moxibustion, where a herbal stick is burned close to the skin to warm and energise acupoints, and Scalp Acupuncture, where specific zones on the scalp are targeted. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Each of these techniques is designed to address specific health concerns while also improving overall well-being. Benefits of Acupuncture Acupuncture is more than just needles, pain, slight bloodletting, and traditional therapy. It is a practice that helps restore the body's inner energy and helps with better function. And while most people think that Acupuncture is just needles and pain, it also has analgesic effects, where, by stimulating the nervous system, it increases the body's natural painkillers like endorphins and enkephalins, providing relief from chronic pain, migraines, joint pain, and more. Plus, Acupuncture is also believed to benefit the central nervous system, reducing harmful brainwaves and helping restore a state of calm and balance. It also supports the immune system by improving energy flow and blood circulation, and helps to enhance white blood cell activity, increasing antibody production, and balancing immune responses. One step to a healthier you—join Times Health+ Yoga and feel the change
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
AMR crisis: Centre asks states to monitor antibiotic use in animals
In an effort to tackle the growing problem of antimicrobial resistance (AMR), which is estimated to claim 2 million lives in India by 2050, the Central Drugs Standard Control Organisation (CDSCO) has asked all state drug controllers to support the development of an antimicrobial use (AMU) reporting framework. The aim is to strengthen monitoring of antibiotic use in animals. For the first time, a joint working group will be formed, comprising representatives from the CDSCO, state licensing authorities (SLAs), and the Department of Animal Husbandry and Dairying (DAHD), to facilitate the implementation of the framework. Officials in the know said the framework will focus on the systematic collection of data on the sale, manufacture, and import of antibiotics for veterinary use. This move follows the Centre's release of the Standard Veterinary Treatment Guidelines for Livestock and Poultry (SVTG) in October last year. The guidelines emphasise minimising antibiotic use to prevent AMR in animals, mirroring similar efforts in human health. They provide symptomatic treatment guidance until a disease is laboratory-confirmed, ensuring minimal or no antibiotic use unless necessary. AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines used to treat humans and animals. According to the World Health Organisation (WHO), around 10 million deaths are projected globally by 2050, with India expected to account for 2 million. In 2019, AMR was directly responsible for 1.27 million deaths globally, while 4.95 million were associated with drug-resistant infections. The WHO notes that the emergence and spread of AMR is accelerated by human activity — mainly the misuse and overuse of antimicrobials to treat, prevent, or control infections in humans, animals, and plants. Vegetables, poultry, and dairy products may contain antibiotic residues, which can enter the human bloodstream when consumed, further aggravating exposure. A recent study published in The Lancet Planetary Health stated that there are bidirectional associations between antibiotic consumption and AMR rates in humans and animals — that is, antibiotic use in animals can lead to AMR in humans, and vice versa. A separate study from 2015 estimated that nearly two-thirds of global antibiotic sales were for animal agriculture, with consumption projected to rise by another 67 per cent by 2030 due to increased demand for livestock products in low- and middle-income countries (LMICs). Coordinated action needed on new framework, says DCGI In a letter to all state and Union Territory (UT) drug controllers, Drug Controller General of India (DCGI) Rajeev Raghuvanshi called for coordinated action on AMU, specifically in the veterinary sector. The letter instructed all SLAs to nominate a nodal officer, not below the rank of assistant or joint drugs controller, to act as the point of contact for AMU data collection and coordination with the joint working group. It also asked state regulators to provide a comprehensive list of pharmaceutical companies involved in the manufacturing, distribution, and sale of veterinary antibiotics within their respective jurisdictions. In a separate letter dated 5 June, the DCGI also asked all zonal and sub-zonal offices of the CDSCO to share a list of approved drugs — including antibiotics, fixed drug combinations (FDCs), and their premixes — for veterinary use. A framework for AMU reporting is being seen as another key step to address AMR. Just last month, the central drug regulator released a draft guidance document for the safe disposal of unused or expired drugs, aimed at preventing AMR and other public health risks. The Centre had also urged pharmacists last year to dispense antibiotics only on the prescription of a qualified doctor, thereby limiting over-the-counter (OTC) sales. Under the Drugs and Cosmetics Rules, antibiotics are included in Schedule H — a list of drugs that may be sold by retail only on the prescription of a Registered Medical Practitioner (RMP).
